Inventor · disambiguated record
Majid Ghoddusi
Also filed as: GHODDUSI MAJID
4 granted patents·4 pending applications·9 citations·filing 2016–2025
68Inventor score
Files withFIVE PRIME THERAPEUTICS INC8
Top patents by PatentIndex Score
8 records- 0191US11306144B2B7-H4 antibodies and methods of use thereofFIVE PRIME THERAPEUTICS INC·Filed 2018·Granted Apr 19, 2022·6 cites·45 claims
- 0290US11814431B2B7-H4 antibodies and methods of use thereofFIVE PRIME THERAPEUTICS INC·Filed 2020·Granted Nov 14, 2023·3 cites·48 claims
- 0381US2024043542A1B7-h4 antibodies and methods of use thereofFIVE PRIME THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0472US2023013293A1B7-h4 antibodies and methods of use thereofFIVE PRIME THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0569US2023052212A1Fgfr2 inhibitors alone or in combination with immune stimulating agents in cancer treatmentFIVE PRIME THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0665US2025223367A1Fgfr2 inhibitors alone or in combination with immune stimulating agents in cancer treatmentFIVE PRIME THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0756US11447553B2FGFR2 inhibitors alone or in combination with immune stimulating agents in cancer treatmentFIVE PRIME THERAPEUTICS INC·Filed 2016·Granted Sep 20, 2022·0 cites·10 claims
- 0854US11939383B2B7-H4 antibodies and methods and use thereofFIVE PRIME THERAPEUTICS INC·Filed 2020·Granted Mar 26, 2024·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Majid Ghoddusi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →